American Century Companies’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,620
Closed -$215K 2886
2023
Q2
$215K Buy
+12,620
New +$185K ﹤0.01% 2509

Other funds holding RCEL

American Century Companies's RCEL Position: Q3 2023 in Review

American Century Companies sold out of Avita Medical (RCEL) in Q3 2023, closing a stake of 12,620 shares — an estimated $215K sold.

American Century Companies first reported a position in RCEL in Q2 2023 and held it in 1 quarter. The position peaked at $215K in Q2 2023. 80 funds tracked by Wall St. Rank hold RCEL as of Q3 2023.

  • American Century Companies reported no remaining Avita Medical position as of Q3 2023 after selling out during the quarter.
  • American Century Companies sold 12,620 Avita Medical shares in Q3 2023, an estimated $215K.
  • American Century Companies first reported a position in Avita Medical in Q2 2023 and held it in 1 quarter.
  • American Century Companies's Avita Medical position peaked at $215K in Q2 2023.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q3 2023.

Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.